Fortis Healthcare Limited (FORTIS): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Fortis Healthcare Limited, explained in plain English.

• ▪Fortis Healthcare Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪FORTIS closed at ₹821.05 on 5 November 2026.
• ▪Over the past year the shares are down 18.7%, trading between ₹704.95 and ₹1,029.90.
• ▪Reported fundamentals show a net margin of 11.02%, debt to equity of 34.15.
• ▪Our transparent MaxGrade checklist scores it F (30/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 26.27% with a maximum drawdown of -30.11% and a beta of 0.74 against NIFTY 50.
• ▪Recent coverage: Q2 Results Live Updates: LG Electronics, Bharti Airtel, Abbott India, Astral, Bharat Forge, Berger Paints, Emami, Fortis Healthcare Earnings In Focus

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma

Figures from the current session. Market open.